Literature DB >> 26800307

LDL accelerates monocyte to macrophage differentiation: Effects on adhesion and anoikis.

R Escate1, T Padro1, L Badimon2.   

Abstract

BACKGROUND AND AIMS: High LDL triggers dyslipidemia and atherosclerosis, a chronic inflammatory disease with participation of the innate immunity system. Monocytes are recruited to areas of LDL-induced endothelial damage and initiate differentiation. This study was aimed to investigate the effects of LDL on the early transitional stages of monocyte differentiation into macrophages.
METHODS: Blood monocytes, isolated from healthy donors by their adhesion properties, were exposed to native-LDL (1.80 mg/mL) for 48-h. Monocyte phenotype was assessed at transcript and miRNA levels by real-time PCR. Protein-expression was determined by western-blot and flow-cytometry.
RESULTS: CD14 time-dependently decreased in adhered monocytes, reaching a >4 fold decrease at transcript- and protein-levels after 7-days in culture when cells were already differentiated into macrophages. At 4-days differentiation, monocytes exposed to LDL reduced CD14-transcrition >1.5 fold in mRNA (p = 0.002) and 34% CD14-protein (p = 0.039), whereas increased in CD16-expression (p = 0.019). Besides, LDL induced a significant increase in integrin CD49c (α3-subunit) at mRNA (>2 fold, p = 0.008) and protein (>3 fold, p = 0.045) level and a decrease in the apoptosis-effectors CASP8 and CASP3 (p = 0.002 and p = 0.035, respectively) as well as in the precursor form of the death-receptor DR5 (p = 0.045) without affecting its mRNA-expression level, suggesting a LDL-dependent post-transcriptional regulation of DR5. In silico prediction analysis indicated miR-126-3p as a candidate to regulate DR5-expression and miR-126-3p was shown affected by LDL reaching a significant increase (p = 0.033).
CONCLUSIONS: In differentiating human monocytes, LDL stimulates expression of cell-adhesion molecules and downregulates apoptosis-effectors, regulating anoikis and survival programs in the early stage macrophages.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Anoikis; Atherosclerosis; Integrins; Monocyte; microRNAs

Mesh:

Substances:

Year:  2016        PMID: 26800307     DOI: 10.1016/j.atherosclerosis.2016.01.002

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  11 in total

1.  CD13 deficiency leads to increased oxidative stress and larger atherosclerotic lesions.

Authors:  Charan V Devarakonda; Flavia E Pereira; Jonathan D Smith; Linda H Shapiro; Mallika Ghosh
Journal:  Atherosclerosis       Date:  2019-06-13       Impact factor: 5.162

Review 2.  Identifying the anti-inflammatory response to lipid lowering therapy: a position paper from the working group on atherosclerosis and vascular biology of the European Society of Cardiology.

Authors:  José Tuñón; Lina Badimón; Marie-Luce Bochaton-Piallat; Bertrand Cariou; Mat J Daemen; Jesus Egido; Paul C Evans; Imo E Hoefer; Daniel F J Ketelhuth; Esther Lutgens; Christian M Matter; Claudia Monaco; Sabine Steffens; Erik Stroes; Cécile Vindis; Christian Weber; Magnus Bäck
Journal:  Cardiovasc Res       Date:  2019-01-01       Impact factor: 10.787

3.  Regulatory Factor X1 Downregulation Contributes to Monocyte Chemoattractant Protein-1 Overexpression in CD14+ Monocytes via Epigenetic Mechanisms in Coronary Heart Disease.

Authors:  Sujie Jia; Shuang Yang; Pei Du; Keqin Gao; Yu Cao; Baige Yao; Ren Guo; Ming Zhao
Journal:  Front Genet       Date:  2019-11-01       Impact factor: 4.599

4.  Survey of In Vitro Model Systems for Investigation of Key Cellular Processes Associated with Atherosclerosis.

Authors:  Dipak P Ramji; Alaa Ismail; Jing Chen; Fahad Alradi; Sulaiman Al Alawi
Journal:  Methods Mol Biol       Date:  2022

5.  Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis.

Authors:  Sean Allen; Yu-Gang Liu; Evan Scott
Journal:  Regen Eng Transl Med       Date:  2016-03-03

6.  Candida albicans β-Glucan Differentiates Human Monocytes Into a Specific Subset of Macrophages.

Authors:  Julia Leonhardt; Silke Große; Christian Marx; Fatina Siwczak; Sven Stengel; Tony Bruns; Reinhard Bauer; Michael Kiehntopf; David L Williams; Zhao-Qi Wang; Alexander S Mosig; Sebastian Weis; Michael Bauer; Regine Heller
Journal:  Front Immunol       Date:  2018-11-30       Impact factor: 7.561

7.  Neutrophil-derived trail is a proinflammatory subtype of neutrophil-derived extracellular vesicles.

Authors:  Young-Jin Youn; Sanjeeb Shrestha; Yu-Bin Lee; Jun-Kyu Kim; Jee Hyun Lee; Keun Hur; Nanda Maya Mali; Sung-Wook Nam; Sun-Hwa Kim; Sunwoong Lee; Dong-Keun Song; Hee Kyung Jin; Jae-Sung Bae; Chang-Won Hong
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

8.  Alternative C3 Complement System: Lipids and Atherosclerosis.

Authors:  Maisa Garcia-Arguinzonis; Elisa Diaz-Riera; Esther Peña; Rafael Escate; Oriol Juan-Babot; Pedro Mata; Lina Badimon; Teresa Padro
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

9.  Macrophages of genetically characterized familial hypercholesterolaemia patients show up-regulation of LDL-receptor-related proteins.

Authors:  Rafael Escate; Teresa Padro; Maria Borrell-Pages; Rosa Suades; Rosa Aledo; Pedro Mata; Lina Badimon
Journal:  J Cell Mol Med       Date:  2016-09-29       Impact factor: 5.310

10.  High-density lipoprotein remodelled in hypercholesterolaemic blood induce epigenetically driven down-regulation of endothelial HIF-1α expression in a preclinical animal model.

Authors:  Soumaya Ben-Aicha; Rafael Escate; Laura Casaní; Teresa Padró; Esther Peña; Gemma Arderiu; Guiomar Mendieta; Lina Badimón; Gemma Vilahur
Journal:  Cardiovasc Res       Date:  2020-06-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.